Skip to main content

Table 2 eRAPID RCT in systemic cancer treatment: Researcher collected data for secondary outcomes

From: Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatment

Data Description of data Time point for collection
Treatment and clinical information • Cancer diagnosis, stage and grade Initial baseline assessment and reviewed for changes at 18 weeks
• Age, date of birth
• Baseline data on planned chemotherapy
• Changes to treatment delivery and reason
• Comorbidities
Clinical process- Hospital contacts • Contacts with the hospital e.g. (unplanned) telephone, appointments, consultations • Data extracted from medical notes for 18 of study
• Emergency admissions, acute ward stays and reasons for contacts.
• 3 month prior to 12 month follow-up assessment
Clinical process- Information from general practice • GP recorded problems/concurrent illnesses • Data extracted from medical notes for 18 week study period
• Prescribed medications and reasons for prescription (where available)
• 3 month period prior to 12 month follow-up assessment for subset of participants
IT/System functioning • Researcher maintained log of IT issues (e.g. server downtime, contacts with study participants reporting IT problems or issues logging into eRAPID) and how these were resolved Throughout trial
Treatment and clinical information • Cancer diagnosis, stage and grade Initial baseline assessment and reviewed for changes at 18 weeks
• Age, date of birth
• Baseline data on planned chemotherapy
• Changes to treatment delivery and reason
• Comorbidities
Clinical process- Hospital contacts • Contacts with the hospital e.g. (unplanned) telephone, appointments, consultations • Data extracted from medical notes for 18 of study
• Emergency admissions, acute ward stays and reasons for contacts. • 3 month prior to 12 month follow-up assessment
Clinical process- Information from general practice • GP recorded problems/concurrent illnesses • Data extracted from medical notes for 18 week study period
• Prescribed medications and reasons for prescription (where available)
• 3 month period prior to 12 month follow-up assessment for subset of participants
IT/System functioning • Researcher maintained log of IT issues (e.g. server downtime, contacts with study participants reporting IT problems or issues logging into eRAPID) and how these were resolved Throughout trial